Related Experiment Video
Updated: Apr 24, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Risk of Multiple Sclerosis Among Persons with Epstein Barr Virus-Positive Mononucleosis: A Population-Based Study
Jennifer L St Sauver1, Susan Audrey Hall2, Robert M Jacobson3
1Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Background And Objective:
Prior studies examining associations between Epstein Barr Virus (EBV)-positive infectious mononucleosis (IM) and risk of multiple sclerosis (MS) frequently lacked laboratory confirmation of EBV-positive IM or relied on billing codes to identify MS. We assessed whether laboratory-confirmed EBV-positive IM was associated with an increased risk of developing verified cases of MS.
Methods:
We conducted a population-based retrospective cohort study using medical records from the Rochester Epidemiology Project. We identified individuals with serologic evidence of EBV infection and an associated IM diagnosis (EBV-positive IM; exposed cohort) between 1998 and 2022. Age- (± 1 year) and sex-matched individuals without evidence of IM (3:1 match) comprised the unexposed cohort. Incident MS cases were verified through blinded expert chart review. Multivariate Cox proportional hazard models were used to assess associations between EBV-positive IM and risk of MS.
Results:
4,721 persons had EBV-positive IM (exposed cohort: 55% female, 70% <20 years). The referent cohort included 14,163 persons without EBV-positive IM (55% female, 70% <20 years). During follow-up (median, 6 years for exposed; 8 years for referents), MS developed in 8 individuals with EBV-positive IM (0.17%) and 10 referents (0.07%). EBV-positive IM was associated with a >3-fold increased risk of MS (adjusted Hazard Ratio: 3.14, 95% Confidence Interval: 1.18-8.34).
Discussion:
EBV-positive IM was associated with a substantially higher risk of MS. Findings are consistent with prior studies and underscore the importance of preventive strategies targeting EBV to reduce the long-term burden of MS.
Insights
Epstein Barr Virus (EBV)-positive infectious mononucleosis (IM) significantly increases the risk of developing multiple sclerosis (MS). This study confirms a strong association between laboratory-confirmed EBV-positive IM and a higher likelihood of MS diagnosis.
Area of Science:
- Neurology
- Virology
- Epidemiology
Background:
- Previous studies on Epstein Barr Virus (EBV)-positive infectious mononucleosis (IM) and multiple sclerosis (MS) risk often lacked laboratory confirmation or relied on less precise diagnostic methods.
- This research addresses limitations by focusing on laboratory-confirmed EBV-positive IM and verified MS cases.
Purpose of the Study:
- To determine if laboratory-confirmed EBV-positive IM is associated with an increased risk of developing multiple sclerosis (MS).
- To provide robust evidence for the link between EBV infection during mononucleosis and subsequent MS development.
Main Methods:
- A population-based retrospective cohort study was conducted using medical records from the Rochester Epidemiology Project.
- Individuals with laboratory-confirmed EBV-positive IM were identified and matched with a control group without IM.
- Multivariate Cox proportional hazard models were employed to analyze the association between EBV-positive IM and MS risk, with MS cases verified by expert chart review.
Main Results:
- The study included 4,721 individuals with EBV-positive IM and 14,163 controls.
- During follow-up, 0.17% of the EBV-positive IM group developed MS, compared to 0.07% in the control group.
- EBV-positive IM was associated with a 3.14-fold increased risk of developing MS (aHR: 3.14, 95% CI: 1.18-8.34).
Conclusions:
- Laboratory-confirmed EBV-positive infectious mononucleosis is linked to a substantially higher risk of multiple sclerosis.
- These findings reinforce the importance of investigating preventive strategies targeting EBV to mitigate the long-term impact of MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Arboviral Encephalitis
Cytomegalovirus Disease
Encephalitis l: Introduction
Cross-reactivity
Viral Meningitis

